Brief: Uni-Bio Science Group Says Anabolic Agent For Osteoporosis & Ostealgia UNI-PTH Approved By NMPA For Clinical Trial
04/09/2020 11:52
Sept 4 (Reuters) - Uni-Bio Science Group Ltd 0690.HK :
* UNI-PTH APPROVED BY NMPA FOR CLINICAL TRIAL
Source text for Eikon: urn:newsml:reuters.com:*:nHKS8PgMHR
Further company coverage: 0690.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Uni-Bio Science
See all newsUni-Bio Science H1 revenue falls 12% on pricing changes
Brief: Uni-Bio Science Expects Net Profit Of Hk$30 Million For Six Months Ended June 2026
Brief: Uni-Bio Science Signs Agreement With WMU NERC And Wenzhou Ouhai District Government
Brief: Uni-Bio Science's Unit Expands Global Reach Of Bogutai Through Strategic Partnership
Brief: Uni-Bio Science Group Says Marketing Application Of Isavuconazonium- Sulfate Capsules Accepted NMPA